GSK’s B7-H3-targeted ADC, GSK’227, receives EMA PRIME designation in relapsed extensive-stage small-cell lung cancer: London, UK Tuesday, December 17, 2024, 12:00 Hrs [IST] GS ...

Pharmaust Limited (AU:NUZ) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ranked ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 496.78% and ...

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...

The Danish Medicines Agency had been watching reports of a rare eye disease in patients who took Novo’s GLP-1 drug but until ...

Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic ...

The drug has received a nod from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP).

GSK (GSK) announced that the European Medicines Agency, EMA, has granted Priority Medicines, PRIME, Designation for GSK5764227, its ...

In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

GSK's cancer drug Jemperli cleared an important hurdle ahead of potentially expanding its European Union marketing permission, in a boost to the pharmaceutical giant's oncology pipeline.

The Danish Medicines Agency said it would ask European authorities to review two new studies that point to a link between ...